| 產(chǎn)品名稱 |
B69 |
| 商品貨號 |
B163985 |
| Organism |
Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type |
hybridoma: B lymphocyte |
| Product Format |
frozen |
| Morphology |
lymphoblast |
| Culture Properties |
suspension |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications |
The antibody binds to and neutralizes most strains of IBD virus. |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Derivation |
Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed |
immunoglobulin; monoclonal antibody; against Infectious Bursal Disease (IBD) virus |
| Cellular Products |
immunoglobulin; monoclonal antibody; against Infectious Bursal Disease (IBD) virus |
| Comments |
Animals were immunized with IBD virus. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody binds to and neutralizes most strains of IBD virus. It does not react with a newly identified variant of IBD virus. |
| Complete Growth Medium |
Dulbecco's modified Eagle's medium with 4.5 g/L glucose, 85%; fetal bovine serum, 15% - OR - RPMI 1640 medium, 85%; fetal bovine serum, 15%
|
| Subculturing |
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation |
Culture medium, 95%; DMSO, 5% |
| Isotype |
IgG2a; kappa light chain |
| Name of Depositor |
Univ. of Maryland |
| Deposited As |
mouse (B cell); mouse (myeloma) |
| U.S. Patent Number |
|
| References |
Snyder DB. Novel infectious bursal disease virus. US Patent 5,064,646 dated Nov 12 1991
|
